Search research articles
Contact Us
Filters
Showing results (1-10 of 48) with videos related to
Page
of 5
Sort By:
CNS Drugs
|
December 16, 2015
Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer's Disease and Other Neurodegenerative Diseases
Valeria Calsolaro, Paul Edison
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
|
June 17, 2016
Alterations in Glucose Metabolism in Alzheimer's Disease
Valeria Calsolaro, Paul Edison
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 16, 2016
Neuroinflammation in Alzheimer's disease: Current evidence and future directions
Valeria Calsolaro, Paul Edison
Frontiers in Pharmacology
|
January 11, 2020
The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer's Disease
Valeria Calsolaro, Rachele Antognoli, Chukwuma Okoye, et al.
International Journal of Molecular Sciences
|
December 2, 2017
Thyroid Disrupting Chemicals
Valeria Calsolaro, Giuseppe Pasqualetti, Filippo Niccolai, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 8, 2016
Coenzyme Q10 and Neurological Diseases
Michelangelo Mancuso, Daniele Orsucci, Valeria Calsolaro, et al.
Journal of Bioenergetics and Biomembranes
|
October 3, 2009
Is there a primary role of the mitochondrial genome in Alzheimer's disease?
Michelangelo Mancuso, Valeria Calsolaro, Daniele Orsucci, et al.
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
|
July 24, 2014
Cognitive function and quality of life in mild thyroid hormone deficiency
Sara Tognini, Giuseppe Pasqualetti, Valeria Calsolaro, et al.
Advances in Experimental Medicine and Biology
|
August 7, 2010
Clinical features and pathogenesis of Alzheimer's disease: involvement of mitochondria and mitochondrial DNA
Michelangelo Mancuso, Daniele Orsucci, Annalisa LoGerfo, et al.
Minerva Endocrinology
|
January 13, 2021
Endocrine dysfunction and cognitive impairment
Valeria Calsolaro, Marina Bottari, Giulia Coppini, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 48) with videos related to
Sort By:
Page
of 5
CNS Drugs
|
December 16, 2015
Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer's Disease and Other Neurodegenerative Diseases
Valeria Calsolaro, Paul Edison
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
|
June 17, 2016
Alterations in Glucose Metabolism in Alzheimer's Disease
Valeria Calsolaro, Paul Edison
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 16, 2016
Neuroinflammation in Alzheimer's disease: Current evidence and future directions
Valeria Calsolaro, Paul Edison
Frontiers in Pharmacology
|
January 11, 2020
The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer's Disease
Valeria Calsolaro, Rachele Antognoli, Chukwuma Okoye, et al.
International Journal of Molecular Sciences
|
December 2, 2017
Thyroid Disrupting Chemicals
Valeria Calsolaro, Giuseppe Pasqualetti, Filippo Niccolai, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 8, 2016
Coenzyme Q10 and Neurological Diseases
Michelangelo Mancuso, Daniele Orsucci, Valeria Calsolaro, et al.
Journal of Bioenergetics and Biomembranes
|
October 3, 2009
Is there a primary role of the mitochondrial genome in Alzheimer's disease?
Michelangelo Mancuso, Valeria Calsolaro, Daniele Orsucci, et al.
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
|
July 24, 2014
Cognitive function and quality of life in mild thyroid hormone deficiency
Sara Tognini, Giuseppe Pasqualetti, Valeria Calsolaro, et al.
Advances in Experimental Medicine and Biology
|
August 7, 2010
Clinical features and pathogenesis of Alzheimer's disease: involvement of mitochondria and mitochondrial DNA
Michelangelo Mancuso, Daniele Orsucci, Annalisa LoGerfo, et al.
Minerva Endocrinology
|
January 13, 2021
Endocrine dysfunction and cognitive impairment
Valeria Calsolaro, Marina Bottari, Giulia Coppini, et al.
Page
of 5